Both in Biotechnology
Novavax vs BioCryst Pharmaceuticals
Over the past year NVAX returned +27.4% and BCRX returned +23.5%; their daily moves had a correlation of 0.13.
NVAX +27.4% BCRX +23.5%Growth of $1, one year, split-adjusted
| Metric | NVAX | BCRX |
|---|---|---|
| Price | $10.08 | $8.47 |
| Market cap | $1.66B | $2.16B |
| Today | −3.72% | −0.59% |
| 1 month | −4.9% | +4.3% |
| 6 months | +25.4% | −7.8% |
| Year to date | +50.0% | +8.6% |
| 1 year | +20.3% | +15.9% |
| Revenue growth (YoY) | −76.3% | +33.6% |
| Gross margin | 74.9% | 98.2% |
| Net margin | −94.2% | 35.9% |
| P/E (TTM) | — | — |
| Price / sales | 4.0× | 2.3× |
| Net cash | $422.0M | -$471.6M |
| Dividend yield | — | — |
| Volatility (60d) | 79.8% | 45.1% |
| Short % of float | 30.3% | 10.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).